MedPath

Incidence of Antibiotic Resistant E.Coli in Patients Undergoing Repeat Prostate Biopsy

Completed
Conditions
Bacterial Infection
Registration Number
NCT00915213
Lead Sponsor
University of California, Irvine
Brief Summary

The purpose of this study is to discover how often certain bacteria are found in the rectum at the time of a prostate needle biopsy to diagnose prostate cancer. Certain bacteria are of importance because they can cause serious infection. Antibiotics that urologists commonly use to prevent these bacteria from causing infection are no longer effective. Many physicians around the world are noting increased infections with antibiotic resistant bacteria. Therefore; despite treating patients who are to undergo prostate biopsy with antibiotics, certain patients are being readmitted to the hospital with a serious infection. In order to study the incidence of these particular bacteria, the best method is to culture the bacteria at the time of the biopsy. This involves one rectal culture swab just prior to needle biopsy of the prostate. Once the incidence of these bacteria is known we may take steps to prevent the serious infections that occur as a result of prostate biopsy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
136
Inclusion Criteria
  • adult males
  • repeat prostate biopsy
Exclusion Criteria
  • first time prostate biopsy
  • minors

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

University of California, Irvine Medical Center

🇺🇸

Orange, California, United States

Long Beach Veteran Affairs

🇺🇸

Long Beach, California, United States

Kaiser Permanente

🇺🇸

Irvine, California, United States

© Copyright 2025. All Rights Reserved by MedPath